Minneapolis Hematology and Breast Cancer Conference

By -Meggan McCaslin

Jan 15, 2024

The Minneapolis Hematology and Breast Cancer Conference, is a CME-accredited, in-person hematology oncology conference featuring leading hematology and breast cancer experts. Expert faculty will place key abstract findings from the 65th ASH Annual Meeting (ASH2023) and the San Antonio Breast Cancer Symposium (SABCS2023) into clinical context and discuss how the results may change the current standards of care for patients with benign and malignant hematologic disorders and breast cancer. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

This conference allows attendees an opportunity to discuss current research and advances in the field of hematologic disorders and breast cancer with colleagues and key opinion leaders. The goals of this conference are to review and critically assess the results of practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients.

Summit on Cancer Health Disparities Presents Research on Inequities in Cancer Care

Summit on Cancer Health Disparities Presents Research on Inequities in Cancer Care

BTF Awards

BTF Awards

Strengthening the Fight Against Cancer: The Urgent Need for Expansion at the Binaytara Foundation Cancer Hospital in Janakpurdham, Nepal

Strengthening the Fight Against Cancer: The Urgent Need for Expansion at the Binaytara Foundation Cancer Hospital in Janakpurdham, Nepal